The Food and Drug Authority (FDA) has approved two more Covid-19 vaccines for use in Ghana.
The approval will allow Modena (Spikevax) and Pfizer-BioNtech (Comirnaty) to be imported and distributed in the country.
The two new vaccines will bring the total number of vaccines in Ghana to five (5) including Sputnik V, CovishieidTM, Covid-19 Vaccine Jassen, Moderna (Spikevax), and Pfizer-BioNtech (Comirnaty).
A statement issued by the FDA, July 28, said the authority “continues to use the Emergency Use Authorization (EUA) pathway, which is the accepted procedure for all national regulatory authorities globally, in order to ensure timely access to quality and safe medical products including vaccines during this pandemic.”
It added, “the Authority, therefore, wishes to assure the public that all the approved COVID-19 vaccines have been subjected to rigorous safety parameters and therefore the public are to receive these vaccines without any reservations.”
“The FDA remains committed to safeguarding the health and safety of the public as mandated by the Public Health Act, 2012 (Act 851), the statement added.